Font Size: a A A

Superior Patency of Upper Arm Arteriovenous Fistulae in High Risk Patients

Posted on:2012-11-29Degree:M.DType:Thesis
University:Yale UniversityCandidate:Chiulli, Larissa CatherineFull Text:PDF
GTID:2464390011964734Subject:Health Sciences
Abstract/Summary:
Background. Despite an increased propensity to primary failure in forearm arteriovenous fistulae compared to upper arm fistulae, forearm fistulae remain the preferred primary access type for chronic hemodialysis patients. In a high risk patient population with multiple medical comorbidities associated with requirement for intravenous access we compared the rates of access failure in forearm and upper arm fistulae. Materials and Methods. The records of all patients having primary native arteriovenous fistulae placed between 2004 and 2009 at the VA Connecticut Healthcare system were reviewed (n=118). Primary and secondary patency of upper arm and forearm fistulae were evaluated using Kaplan-Meier survival analysis. The effects of medical comorbidities on access patency were analyzed with Cox regression. Results. The median time to primary failure of the vascular access was 0.288 years in the forearm group compared to 0.940 years in the upper arm group (p=0.028). Secondary patency was 52% at 4.9 years in upper arm fistulae compared to 52% at 1.1 years in the forearm group (p=0.036). There was no significant effect of patient comorbidities on fistula failure; however, there was a trend toward upper arm surgical site as a protective factor for primary fistula patency (Hazard Ratio=0.573, p=0.076). Conclusions. In veterans needing hemodialysis, a high risk population with extensive comorbid factors often requiring intravascular access, upper arm fistulae are not only a viable option for primary vascular access, but are likely to be a superior option to classic forearm fistulae.;Keywords: Arteriovenous fistula, radiocephalic fistula, brachiocephalic fistula, hemodialysis, vascular patency, veteran, risk factor.
Keywords/Search Tags:Fistulae, Upper arm, Arteriovenous, Patency, Risk, Primary, Compared, Failure
Related items